Foot Oliver, Hallin Magnus, Bagué Silvia, Jones Robin L, Thway Khin
The Royal Marsden NHS Foundation Trust, London, UK.
The Institute of Cancer Research, London, UK.
Int J Surg Pathol. 2020 Dec;28(8):879-881. doi: 10.1177/1066896920938133. Epub 2020 Jul 1.
Superficial CD34-positive fibroblastic tumor (SCPFT) is a recently described entity that, despite significant pleomorphism, carries a good prognosis. We briefly describe this tumor and its principal differential diagnoses. Recognition of SCPFTs, including the clinical context in which they arise, is important to avoid confusion with other pleomorphic soft tissue tumors, particularly neoplasms in the group of pleomorphic sarcomas, which are typically aggressive tumors that could lead to unnecessary overtreatment.
浅表性CD34阳性成纤维细胞瘤(SCPFT)是一种最近才被描述的病变,尽管其具有显著的多形性,但预后良好。我们简要描述一下这种肿瘤及其主要的鉴别诊断。认识SCPFTs,包括其发生的临床背景,对于避免与其他多形性软组织肿瘤混淆很重要,尤其是多形性肉瘤组中的肿瘤,这些通常是侵袭性肿瘤,可能导致不必要的过度治疗。